Home>Patient Education Patient Counseling Tools Patient counseling brochure (available in English and Spanish) Explains the basics of stroke and presents the potential benefits of treatment with Activase (t-PA), and post-discharge rehabilitation Patient counseling flashcards Easy-to-read flashcards demonstrate what happens during an acute ischemic stroke, and show how Activase (t-PA) may help reverse detrimental neurologic effects No Opportunity Wasted Video Genentech collaborated with leading physicians in stroke treatment to develop a video for stroke patients, those at risk for stroke, and their families RealPlayer® required If you do not have RealPlayer installed, download now to view the video. Genentech® Access to Care Foundation Although Genentech's products are covered by most government and private insurance, Genentech has established the Genentech® Access to Care Foundation for each of its marketed products to make them available to qualified uninsured or underinsured patients in the United States For consideration of eligibility for resources from the Genentech® Access to Care Foundation, the patient must qualify based on income restrictions and be uninsured or rendered uninsured by payer denial. Please direct requests for application forms and more specific information on eligibility to: Genentech Access to Care Foundation 1 DNA Way MS #13A South San Francisco, CA 94080 (800) 530-3083 FAX: (650) 225-1366

Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset of stroke symptoms, and after exclusion of intracranial hemorrhage by a cranial computerized tomography (CT) scan or other diagnostic imaging method sensitive for the presence of hemorrhage (see CONTRAINDICATIONS in the full prescribing information).

Safety Information: All thrombolytic agents increase the risk of bleeding, including intracranial bleeding, and should be used only in appropriate patients. Not all patients with acute ischemic stroke will be eligible for Activase therapy, including patients with evidence of recent or active bleeding; recent (within 3 months) intracranial or intraspinal surgery, serious head trauma, or previous stroke; uncontrolled high blood pressure; or impaired blood clotting.

Please see full prescribing information.